Trial of Variable Dialysate Bicarbonate

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-120
SponsorBrigham and Women's Hospital

About this trial

QTc prolongation and premature ventricular contractions (PVCs) are common in hemodialysis (HD) patients and are associated with sudden cardiac death.

It is known that higher dialysate bicarbonate is associated with more QTc prolongation during HD sessions.

This study aims to assess the effects of lower (30 mEq/L) versus higher (35 mEq/L) dialysate bicarbonate in adult maintenance HD patients admitted to the hospital.

The investigators will randomly assign subjects to lower versus higher dialysate bicarbonate concentrations during their hospital stay for up to a maximum of six HD sessions or until their hospital discharge.

Eligibility criteria

Qualifiers

prevalent end-stage renal disease, on maintenance HD > 90 days

age ≥ 18 years old

thrice weekly HD

Disqualifiers

hemoglobin < 8.0 g/dL

pregnancy

any physical, mental or medical condition which limited the ability to provide written informed consent

Trial design

Treatments tested in this trial

  • Dialysate bicarbonate concentration
  • Dialysate bicarbonate concentration - telemetry monitoring

Treatment groups

141 Participants
are divided into 2 treatment groups

Sponsors and collaborators